Oral HerpesSymptoms, Doctors, Treatments, Advances & More
Oral Herpes Overview
Learn About Oral Herpes
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Beate Sodeik practices practicing medicine in Hannover, Germany. Ms. Sodeik is rated as an Elite expert by MediFind in the treatment of Oral Herpes. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Oral Herpes, Herpes Simplex Encephalitis, Encephalitis, and Togaviridae Disease.
Lars Dolken practices practicing medicine in Wuerzburg, Germany. Mr. Dolken is rated as an Elite expert by MediFind in the treatment of Oral Herpes. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Oral Herpes, Cytomegalovirus Infection, Cytomegalic Inclusion Disease, and Severe Acute Respiratory Syndrome (SARS).
Giovanna De Chiara practices practicing medicine in Rome, Italy. Ms. De Chiara is rated as an Elite expert by MediFind in the treatment of Oral Herpes. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Oral Herpes, Memory Loss, Alzheimer's Disease, and Dementia.
Summary: This is a Phase 1 open label study designed to assess the safety and tolerability of the oncolytic herpes simplex virus 1 (oHSV1) study drug, MVR-C5252, administered intratumorally by convection-enhanced delivery (CED) in patients with recurrent high-grade glioma. Once the safety and maximum tolerated dose (MTD) is established in the dose escalation portion of the trial, a dose expansion cohort at...
Summary: This early-phase study will examine Vusolimogene Oderparepvec, a genetically modified oncolytic viral strain of the herpes simplex type 1 (HSV-1) virus, with potential oncolytic, immunostimulating and antineoplastic activities. Upon administration, vusolimogene oderparepvec specifically targets, infects and replicates in tumor cells and does not infect healthy cells. This results in tumor cell lys...

